Peter Salzmann is CEO at Immunovant, Inc. (IMVT). They have made 33 open-market trades across 1 company since 2022, most recently 2025-04-16.
CIK 0001796309
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 33 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2025-04-16 | 2025-04-17 | $14.89 | $248K | +10.4% | +0.5% | +21.7% |
| IMVT | SELL | 2025-04-09 | 2025-04-11 | $12.99 | $730K | -0.6% | -4.0% | +15.4% |
| IMVT | SELL | 2025-02-19 | 2025-02-21 | $20.86 | $644K | -8.4% | -8.3% | -31.4% |
| IMVT | SELL | 2025-01-15 | 2025-01-17 | $23.82 | $408K | -8.2% | -13.4% | -37.0% |
| IMVT | SELL | 2025-01-08 | 2025-01-10 | $24.10 | $246K | +2.8% | -14.3% | -35.0% |
| IMVT | SELL | 2024-11-20 | 2024-11-22 | $25.45 | $850K | +4.4% | -5.3% | -24.8% |
| IMVT | SELL | 2024-10-16 | 2024-10-18 | $28.79 | $524K | +2.3% | -13.6% | -19.3% |
| IMVT | SELL | 2024-10-09 | 2024-10-11 | $29.56 | $264K | -1.4% | +2.3% | -22.9% |
| IMVT | SELL | 2024-08-21 | 2024-08-23 | $31.85 | $941K | +3.8% | -12.5% | -18.1% |
| IMVT | SELL | 2024-07-17 | 2024-07-19 | $29.69 | $258K | +3.1% | +10.6% | +3.8% |
| IMVT | SELL | 2024-07-09 | 2024-07-10 | $28.06 | $259K | -9.4% | -5.4% | -4.1% |
| IMVT | SELL | 2024-05-22 | 2024-05-24 | $29.65 | $958K | -12.7% | -6.1% | +7.8% |
| IMVT | SELL | 2024-04-17 | 2024-04-19 | $29.22 | $1.2M | -0.2% | +8.0% | -0.6% |
| IMVT | SELL | 2024-04-09 | 2024-04-10 | $31.18 | $300K | -6.4% | -4.3% | -3.3% |
| IMVT | SELL | 2024-02-22 | 2024-02-23 | $36.15 | $973K | -9.8% | -14.8% | -22.5% |
| IMVT | SELL | 2024-01-05 | 2024-01-09 | $38.59 | $295K | -8.7% | -19.5% | -30.4% |
| IMVT | SELL | 2023-11-22 | 2023-11-24 | $32.76 | $1.0M | +16.8% | +32.2% | +7.7% |
| IMVT | SELL | 2023-10-05 | 2023-10-06 | $36.31 | $348K | +3.4% | -5.5% | +8.9% |
| IMVT | SELL | 2023-08-30 | 2023-09-01 | $22.02 | $2.5M | -7.6% | +45.4% | +64.3% |
| IMVT | SELL | 2023-08-14 | 2023-08-16 | $21.42 | $4.4M | +2.7% | +6.5% | +70.7% |
| IMVT | SELL | 2023-08-07 | 2023-08-08 | $21.73 | $4.4M | -1.5% | +10.6% | +62.3% |
| IMVT | SELL | 2023-07-12 | 2023-07-13 | $19.73 | $128K | +7.5% | +5.0% | +81.0% |
| IMVT | SELL | 2023-04-18 | 2023-04-19 | $15.27 | $104K | +13.1% | +36.1% | +60.1% |
| IMVT | SELL | 2023-01-11 | 2023-01-13 | $16.80 | $135K | -3.5% | -0.8% | -15.8% |
| IMVT | SELL | 2022-10-13 | 2022-10-17 | $9.18 | $26K | +10.6% | +41.1% | +91.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.